Thiopurine Dose in Intermediate and Normal Metabolizers of Thiopurine Methyltransferase May Differ Three-Fold  Sharon J. Gardiner, Richard B. Gearry,

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

6-Thioguanosine Diphosphate and Triphosphate Levels in Red Blood Cells and Response to Azathioprine Therapy in Crohn’s Disease  Markus F. Neurath, Ralf.
The Role of Psychosocial Care in Adapting to Health Care Reform
Volume 122, Issue 4, Pages (April 2002)
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Glomus Tumor of the Stomach—A Tumor That Needs to Be Differentiated From Gastrointestinal Stromal Tumor  Shuisheng Zhang, Jianwei Zhang, Chengfeng Wang 
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Pharmacogenomics in Inflammatory Bowel Disease
Value of Spatiotemporal Representation of Manometric Data
Pichamol Jirapinyo, Christopher C. Thompson 
Celiac Disease and Persistent Symptoms
A Shocking Cystory Clinical Gastroenterology and Hepatology
Todd H. Baron, MD, Thomas C. Smyrk, MD 
Colonic Amyloidosis Clinical Gastroenterology and Hepatology
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
6-Thioguanosine Diphosphate and Triphosphate Levels in Red Blood Cells and Response to Azathioprine Therapy in Crohn’s Disease  Markus F. Neurath, Ralf.
Rebekah S. Wieland, Richard S. Zubarik, Maryam J. Zenali 
Amit G. Singal, Jasmin A. Tiro, Samir Gupta 
Inosine Triphosphate Pyrophosphatase and Thiopurine S-Methyltransferase Genotypes Relationship to Azathioprine-Induced Myelosuppression  Zuzana Zelinkova,
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Todd H. Baron, Patrick S. Kamath, Robert D. McBane 
Should the Reflex Be Reflux
Endocuff to Improve Adenoma Detection: Supported by Low-Quality Evidence or Not Supported by High-Quality Evidence?  Yao Zhang, MD, Sheng-Bing Zhao, MD 
Granular Cell Tumor in Colonic Polyp Found on Screening Colonoscopy
Reverse Double-Wire Cannulation of the Pancreatic Duct
Miles Basil, Anita Pudusseri, Robert Lowe 
Activity-Based Costing and Management in a Hospital-Based GI Unit
May Min, Jason Ferreira, Charles Wang 
Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased  Fiona D.M. van Schaik, Martijn G.H.
Endoscopic Therapy for Barrett's Esophagus
When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer?  Folasade P. May, Samir Gupta  Clinical Gastroenterology.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
New Models of Gastroenterology Practice
Clinical relevance of advances in genetics and pharmacogenetics of IBD
Volume 122, Issue 4, Pages (April 2002)
Intragastric Fistula After Multiple Sphere Magnet Ingestion
Volume 130, Issue 3, Pages (March 2006)
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Cholelithiasis in a Patient With History of Cholecystectomy
Volume 118, Issue 4, Pages (April 2000)
Azathioprine metabolism.
Patient-Reported Outcomes of Cirrhosis
Issue Highlights Clinical Gastroenterology and Hepatology
Colorectal Cancer Screening: How to Stop a Moving Target
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Initiating Azathioprine for Crohn's Disease
Issue Highlights Clinical Gastroenterology and Hepatology
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Coagulation in Liver Disease: A Guide for the Clinician
Industry Payments to Gastroenterologists Across the United States
Issue Highlights Clinical Gastroenterology and Hepatology
Marla C. Dubinsky  Clinical Gastroenterology and Hepatology 
Volume 122, Issue 3, Pages (March 2002)
Issue Highlights Clinical Gastroenterology and Hepatology
Effect of Allopurinol on Clinical Outcomes in Inflammatory Bowel Disease Nonresponders to Azathioprine or 6-Mercaptopurine  Miles P. Sparrow, Scott A.
Black and White Liver Clinical Gastroenterology and Hepatology
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation  Timothy C. Wang, Rhonda F. Souza  Clinical.
Azathioprine metabolism.
An Unusual Case of Gastritis and Duodenitis After Yttrium 90–Microsphere Selective Internal Radiation  Jessica Baumann, Mark Lin, Charmi Patel  Clinical.
The Role of Psychosocial Care in Adapting to Health Care Reform
Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction
Richard A. Hansen, Gerald Gartlehner, Gregory E. Powell, Robert S
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Thiopurine Dose in Intermediate and Normal Metabolizers of Thiopurine Methyltransferase May Differ Three-Fold  Sharon J. Gardiner, Richard B. Gearry, Evan J. Begg, Mei Zhang, Murray L. Barclay  Clinical Gastroenterology and Hepatology  Volume 6, Issue 6, Pages 654-660 (June 2008) DOI: 10.1016/j.cgh.2008.02.032 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Metabolism of azathioprine and 6-MP. GMPS, guanosine monophosphate synthetase; HGPRT, hypoxanthine guanine phosphoribosyltransferase; IMPDH, inosine monophosphate dehydrogenase; TG, thioguanine; TGMP, thioguanine monophosphate; TGN, thioguanine nucleotides; TIMP, thionosine monophosphate; TXMP, thioxanthosine monophosphate. Clinical Gastroenterology and Hepatology 2008 6, 654-660DOI: (10.1016/j.cgh.2008.02.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 (A) Thiopurine dose (as azathioprine equivalents) in TPMT*1/*1 (Δ) and *1/*3 (○) genotypes and in (B) normal (Δ, ≥9.3 IU/mL) phenotypes and intermediate (○, 5–9.2 IU/mL) and presented as mean and 95% CI. †Groups became significantly different (P < .05). Clinical Gastroenterology and Hepatology 2008 6, 654-660DOI: (10.1016/j.cgh.2008.02.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 TPMT activity versus weight-adjusted thiopurine dose. Clinical Gastroenterology and Hepatology 2008 6, 654-660DOI: (10.1016/j.cgh.2008.02.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 (A) Actual and (B) dose-adjusted 6-TGN concentrations versus TPMT genotype at month 9. Data are presented as mean and 95% CI. Mean actual and dose-adjusted 6-TGN concentrations were 2-fold (P = .016) and 3-fold higher (P = .0007) in the TPMT*1/*3 versus the *1/*1 genotype, respectively. Clinical Gastroenterology and Hepatology 2008 6, 654-660DOI: (10.1016/j.cgh.2008.02.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 Dose-adjusted 6-TGN concentrations versus TPMT activity (includes line of best fit plus 95% CI of this line). Clinical Gastroenterology and Hepatology 2008 6, 654-660DOI: (10.1016/j.cgh.2008.02.032) Copyright © 2008 AGA Institute Terms and Conditions